The three pathways
Todokede (notification), ninsho (RCB certification), and shonin (PMDA/MHLW approval) — with the JMDN classification picture.
Free field guide · PDF
The three pathways, the MAH gate, and the one-stop platform — with the registration practice you need.
Sourced from verified 2026 publications.
Enter your work email and we'll send the PDF straight to your inbox.
What's inside
Every figure in this guide traces to a named source — verified 2026 publications.
Todokede (notification), ninsho (RCB certification), and shonin (PMDA/MHLW approval) — with the JMDN classification picture.
Licensed Japanese MAH on every authorization, the 5-year QMS certificate, and the MAH-replacement power.
The Aug 18, 2026 ENSEMBLExJ one-stop platform for overseas biopharma, plus the enlarged early-approval program.
This guide is market-access intelligence, not regulatory or legal advice. PMDA pathways, timelines, and consultation practice change — professional review is required before business use.
Market Access Strategy Session
A Market Access Strategy Session maps your PMDA route — pathway selection, MAH readiness, and consultation strategy.
Professional review is required before business use.
Back to ghmap.io Questions? Talk to our team